Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

HAART Chart: Approved Antiretroviral Drugs

Winter 2007

Generic (Common) Name Brand Name Company Year Approved
Protease Inhibitors (PIs)
amprenavir Agenerase GlaxoSmithKline 1999; discontinued 2004
atazanavir Reyataz Bristol-Myers Squibb 2003
darunavir (TMC114) Prezista Tibotec 2006
fosamprenavir Lexiva (U.S.); Telzir (Europe) GlaxoSmithKline 2003
indinavir Crixivan Merck 1996
lopinavir/ritonavir Kaletra Abbott 2000; Meltrex formulation 2005
nelfinavir Viracept Pfizer 1997
ritonavir Norvir Abbott 1996
saquinavir Invirase (hard-gel)
Fortovase (soft-gel)
Roche 1995
1997; withdrawn 2005
tipranavir Aptivus Boehringer Ingelheim 2005
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
abacavir Ziagen GlaxoSmithKline 1998
didanosine (ddI) Videx Bristol-Myers Squibb 1989; extended release Videx EC 2000
emtricitabine (FTC) Emtriva Gilead 2003
lamivudine (3TC) Epivir GlaxoSmithKline 1995
stavudine (d4T) Zerit Bristol-Myers Squibb 1994
tenofovir DF Viread Gilead 2002
zalcitabine (ddC) Hivid Roche 1992; withdrawn 2005
zidovudine (AZT) Retrovir GlaxoSmithKline 1987
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdine Rescriptor Pfizer 1997
efavirenz Sustiva (U.S.); Stocrin (elsewhere) Bristol-Myers Squibb 1998
nevirapine Viramune Boehringer Ingelheim 1996
Entry/Fusion Inhibitors
enfuvirtide (T-20) Fuzeon Trimeris 2003
Fixed-Dose Combinations
lamivudine/abacavir (NRTI) Epzicom (U.S.); Kivexa (Europe) GlaxoSmithKline 2004
tenofovir/emtricitabine (NRTI) Truvada Gilead 2004
tenofovir/emtricitabine/
efavirenz (NRTI/NNRTI)
Atripla Gilead/Bristol-Myers Squibb 2006
zidovudine/lamivudine (NRTI) Combivir GlaxoSmithKline 1997
zidovudine/lamivudine/abacavir (NRTI) Trizivir GlaxoSmithKline 2000





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. Visit San Francisco AIDS Foundation's Web site to find out more about their activities, publications and services.
 

Tools
 

Advertisement